Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.


Tillotts Pharma AG (“Tillotts”), part of the Japanese Zeria Group, is a fast-growing specialty pharmaceutical company with over 300 employees worldwide.

News & events

Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease

Newark, DE, USA, 10 June 2024, Mage Biologics (“Mage”) announces it has dosed the firs [...]
Read more »

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis Novel anti [...]
Read more »

Tillotts Pharma AG announces the launch of Octasa® 1600 mg Tablets in Canada

RHEINFELDEN, Switzerland, 06.04.2023 - Tillotts Pharma AG (“Tillotts”), part of the Ja [...]
Read more »

About Tillotts Pharma

A worldwide partner

Today, our products are available in over 65 countries through our affiliates in Europe, our parent company Zeria and a strategic partnership network throughout the world. Tillotts is headquartered in Rheinfelden, Switzerland close to Basel. For more information about Tillotts, please take a look here:

GI health

Improving care for people with GI diseases

Since its foundation, Tillotts has been committed to improving care for people with gastrointestinal (GI) diseases. We collaborate with healthcare professionals and GI-experts to develop and market medicines for the treatment of diseases of the digestive system.

Our specific focus on the digestive system means we have in-depth knowledge of the challenges that gastroenterologists and hepatologists face on a daily basis. It also helps us look for innovative ways to improve care and quality of life for the 5–6 million people who live with inflammatory bowel diseases worldwide.

Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a group of conditions where the body’s own immune system attacks parts of the digest [...]
Read more »

Ulcerative Colitis

Ulcerative colitis (UC) is an inflammatory bowel disease that involves chronic inflammation of the lining of the large b [...]
Read more »

Crohn’s Disease

Crohn’s disease (CD) is an inflammatory bowel disease that is caused by the chronic inflammation of the digestive tract. [...]
Read more »

Microscopic Colitis

Microscopic colitis (MC) is an inflammation of the colon that causes chronic, non-bloody watery diarrhoea. Patients with [...]
Read more »

Clostridium difficile infections

Clostridioides difficile infections (CDI), also known as C. difficile-associated diarrhoea (CDAD), is an infection cause [...]
Read more »

Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a chronic condition of the digestive system. This condition causes abdominal pain and [...]
Read more »

Why Tillotts

What Tillotts can offer you

At Tillotts, we are dedicated to advancing our employees’ skills and supporting them with their professional development. We encourage individuals’ involvement in all aspects of the business in which they are interested, to gain a deeper insight into the full picture. In order to do this, we offer a variety of leadership training and support with further education.